Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Comparison of clinical parameters between patients with osteoporosis alone and patients with osteosarcopenia, overall and according to age category. | All patients (≥65 years) | 65 to 74 years | 75 to 84 years | ≥85 years | All (N = 276) | OP (N = 222) | OS (N = 54) | P value | All (N = 105) | OP (N = 92) | OS (N = 13) | P value | All (N = 126) | OP (N = 99) | OS (N = 28) | P value | All (N = 44) | OP (N = 31) | OS (N = 13) | P value: Vitamin D [N (%)] | 12 (4.3) | 11 (5.0) | 1 (1.9) | 0.32 | 4 (3.8) | 4 (4.3) | 0 (0) | 0.46 | 5 (4.0) | 5 (5.1) | 0 (0) | 0.23 | 3 (6.8) | 2 (6.5) | 1 (7.7) | 0.88

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this retrospective cross-sectional study, the medical records of 609 patients with osteoporosis, who regularly visited Showa University Hospital in Tokyo, Japan, were reviewed.

Source: Methods.

Patients were eligible for the study if they met the following criteria: (1) age ≥ 65 years, (2) diagnosed of postmenopausal osteoporosis, and (3) blood sampling and DXA performed on the same day between October 1, 2016, and September 31, 2017.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Risk factors predicting osteosarcopenia in postmenopausal women with osteoporosis: A retrospective study

Cross-sectional study · PLoS ONE · 2020

Original publication title

Risk factors predicting osteosarcopenia in postmenopausal women with osteoporosis: A retrospective study

Hiroki Okamura; Koji Ishikawa; Yoshifumi Kudo; Akira Matsuoka; Hiroshi Maruyama; Haruka Emori; Ryo Yamamura; Chikara Hayakawa; Soji Tani; Koki Tsuchiya; Toshiyuki Shirahata; Tomoaki Toyone; Takashi Nagai; Katsunori Inagaki

© 2020 Okamura et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

There is growing interest in “osteosarcopenia” as the coexistence of osteoporosis and sarcopenia exacerbates negative outcomes. However, limited information is available regarding the risk factors of osteosarcopenia development in patients with osteoporosis. Therefore, we retrospectively reviewed 276 consecutive patients with postmenopausal osteoporosis who regularly visited Showa University Hospital. Patients were eligible for the study if they were ≥65 years of age and underwent dual-energy X-ray absorptiometry, blood sampling, and physical performance assessment. Patients were divided into the osteosarcopenia and osteoporosis alone groups according to the diagnostic criteria of the Asian Working Group for Sarcopenia.

Of the 276 patients with osteoporosis, 54 patients (19.6%) had osteosarcopenia. Patients in the osteosarcopenia group had a greater risk of frailty than did those in the osteoporosis alone group (odds ratio 2.33; 95% confidence interval, 1.13 to 4.80, P = 0.028). Low body mass index seemed to be the strongest factor related to the development of osteosarcopenia, and none of the patients in the osteosarcopenia group were obese (BMI ≥27.5 kg/m2). Multiple logistic analyses revealed that patients aged 65 to 74 years who had comorbidities such as kidney dysfunction and high levels of HbA1c were at risk of developing osteosarcopenia.

Thus, we strongly recommend the assessment of the key components of the diagnosis of osteosarcopenia in an osteoporosis clinic for patients with low body mass index. Furthermore, appropriate assessments, including comorbidities, will help in identifying patients at greater risk of developing osteosarcopenia.

Authors’ abstract

There is growing interest in “osteosarcopenia” as the coexistence of osteoporosis and sarcopenia exacerbates negative outcomes. However, limited information is available regarding the risk factors of osteosarcopenia development in patients with osteoporosis. Therefore, we retrospectively reviewed 276 consecutive patients with postmenopausal osteoporosis who regularly visited Showa University Hospital. Patients were eligible for the study if they were ≥65 years of age and underwent dual-energy X-ray absorptiometry, blood sampling, and physical performance assessment. Patients were divided into the osteosarcopenia and osteoporosis alone groups according to the diagnostic criteria of the Asian Working Group for Sarcopenia.

Of the 276 patients with osteoporosis, 54 patients (19.6%) had osteosarcopenia. Patients in the osteosarcopenia group had a greater risk of frailty than did those in the osteoporosis alone group (odds ratio 2.33; 95% confidence interval, 1.13 to 4.80, P = 0.028). Low body mass index seemed to be the strongest factor related to the development of osteosarcopenia, and none of the patients in the osteosarcopenia group were obese (BMI ≥27.5 kg/m2). Multiple logistic analyses revealed that patients aged 65 to 74 years who had comorbidities such as kidney dysfunction and high levels of HbA1c were at risk of developing osteosarcopenia.

Thus, we strongly recommend the assessment of the key components of the diagnosis of osteosarcopenia in an osteoporosis clinic for patients with low body mass index. Furthermore, appropriate assessments, including comorbidities, will help in identifying patients at greater risk of developing osteosarcopenia.

Publication and source details

Original title: Risk factors predicting osteosarcopenia in postmenopausal women with osteoporosis: A retrospective study

Hiroki Okamura; Koji Ishikawa; Yoshifumi Kudo; Akira Matsuoka; Hiroshi Maruyama; Haruka Emori; Ryo Yamamura; Chikara Hayakawa; Soji Tani; Koki Tsuchiya; Toshiyuki Shirahata; Tomoaki Toyone; Takashi Nagai; Katsunori Inagaki

PLoS ONE · 2020

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: koji.ishikawa@med.showa-u.ac.jp
© 2020 Okamura et al2020Okamura et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.KAKENHI17K18114;19K18544http://orcid.org/0000-0003-3689-5662Ishikawa Koji Grant of Japan Orthopaedics and Traumatology Research Foundation399http://orcid.org/0000-0003-3689-5662Ishikawa Koji This work was supported by grants awarded to K.I by KAKENHI (17K18114 and 19K18544) (KI) and Grant of Japan Orthopaedics and Traumatology Research Foundation (Grant No.399) (KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T14:46:09.781087+00:00

DOI: 10.1371/journal.pone.0237454 · PMC7413553